Zume
Search results
Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.
Oct 19, 2022 · Ginkgo Bioworks, a company that designs and builds biological systems, announces its completed acquisition of Zymergen, a company that develops automation and software solutions for biological engineering. The acquisition is expected to enhance Ginkgo's platform and expand its product concepts and partnerships.
Oct 13, 2021 · The company behind the ad was Zymergen, a California synthetic biology company that had just gone public with a market capitalization of $3 billion. Its three founders — Josh Hoffman, Zach Serber...
Zymergen | 31,475 followers on LinkedIn. Zymergen is now a part of Ginkgo Bioworks!
Jul 25, 2022 · Zymergen, a synthetic biology company that shifted to drug discovery in January, has been acquired by Ginkgo Bioworks for $300 million. Ginkgo plans to integrate Zymergen's automation and software into its cell engineering platform, while evaluating strategic alternatives for its drug discovery business.
- James Waldron
Jan 10, 2022 · SAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is...
People also ask
What happened to zymergen?
What does zymergen do?
Is zymergen the world's largest metagenomics database?
How did zymergen start?
Is zymergen a part of Ginkgo Bioworks?
Who owns zymergen?
Oct 10, 2020 · In September, Zymergen announced one of the largest deep tech investments of 2020 — $300 million — to accelerate its pipeline of high-performance chemicals and materials.
